Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
81.73
-0.33 (-0.40%)
Dec 5, 2025, 4:00 PM EST - Market closed

PBE Holdings List

Dec 3, 2025
No.SymbolName WeightShares
1ALNYAlnylam Pharmaceuticals, Inc.5.39%29,494
2AMGNAmgen Inc.5.11%38,293
3BIIBBiogen Inc.5.06%72,430
4ILMNIllumina, Inc.5.02%101,676
5UTHRUnited Therapeutics Corporation4.98%26,838
6GILDGilead Sciences, Inc.4.93%102,236
7INCYIncyte Corporation4.72%120,549
8REGNRegeneron Pharmaceuticals, Inc.4.70%16,819
9BCRXBioCryst Pharmaceuticals, Inc.3.10%1,022,796
10MNKDMannKind Corporation2.94%1,361,734
11ACADACADIA Pharmaceuticals Inc.2.92%292,289
12NBIXNeurocrine Biosciences, Inc.2.90%49,456
13COLLCollegium Pharmaceutical, Inc.2.83%153,076
14IONSIonis Pharmaceuticals, Inc.2.81%88,967
15EXELExelixis, Inc.2.81%165,342
16VCYTVeracyte, Inc.2.76%149,587
17TECHBio-Techne Corporation2.71%110,028
18RPRXRoyalty Pharma plc2.69%175,741
19RGENRepligen Corporation2.69%41,766
20QGENQiagen N.V.2.67%147,939
21FOLDAmicus Therapeutics, Inc.2.67%706,339
22TGTXTG Therapeutics, Inc.2.66%218,099
23MDGLMadrigal Pharmaceuticals, Inc.2.66%11,882
24CPRXCatalyst Pharmaceuticals, Inc.2.65%296,898
25PTGXProtagonist Therapeutics, Inc.2.65%79,664
As of Dec 3, 2025